CA2384525A1 - Thienylhydrazone possedant des proprietes analogues a celles de la digitale (effets inotropes positifs) - Google Patents
Thienylhydrazone possedant des proprietes analogues a celles de la digitale (effets inotropes positifs) Download PDFInfo
- Publication number
- CA2384525A1 CA2384525A1 CA002384525A CA2384525A CA2384525A1 CA 2384525 A1 CA2384525 A1 CA 2384525A1 CA 002384525 A CA002384525 A CA 002384525A CA 2384525 A CA2384525 A CA 2384525A CA 2384525 A1 CA2384525 A1 CA 2384525A1
- Authority
- CA
- Canada
- Prior art keywords
- digitalis
- properties
- positive inotropic
- thienylhydrazon
- lassbio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000009090 positive inotropic effect Effects 0.000 title abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- YMOJHAPRGAZUPL-VGOFMYFVSA-N n-[(e)-thiophen-2-ylmethylideneamino]-1,3-benzodioxole-5-carboxamide Chemical compound C=1C=C2OCOC2=CC=1C(=O)N\N=C\C1=CC=CS1 YMOJHAPRGAZUPL-VGOFMYFVSA-N 0.000 abstract 2
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010049565 Muscle fatigue Diseases 0.000 abstract 1
- 150000001336 alkenes Chemical class 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940082657 digitalis glycosides Drugs 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 210000004165 myocardium Anatomy 0.000 abstract 1
- 150000002989 phenols Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000002027 skeletal muscle Anatomy 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14035299P | 1999-06-21 | 1999-06-21 | |
| US60/140,352 | 1999-06-21 | ||
| PCT/US2000/017024 WO2000078754A1 (fr) | 1999-06-21 | 2000-06-21 | Thienylhydrazone possedant des proprietes analogues a celles de la digitale (effets inotropes positifs) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2384525A1 true CA2384525A1 (fr) | 2000-12-28 |
| CA2384525C CA2384525C (fr) | 2007-03-06 |
Family
ID=22490853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002384525A Expired - Fee Related CA2384525C (fr) | 1999-06-21 | 2000-06-21 | Thienylhydrazone possedant des proprietes analogues a celles de la digitale (effets inotropes positifs) |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1532140A1 (fr) |
| AU (1) | AU5628700A (fr) |
| CA (1) | CA2384525C (fr) |
| WO (1) | WO2000078754A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0403363A (pt) * | 2004-08-20 | 2006-05-02 | Univ Rio De Janeiro | relaxantes musculares seletivos e composições farmacêuticas |
| BRPI0601885A (pt) * | 2006-05-15 | 2008-03-25 | Univ Rio De Janeiro | composição farmacêutica antiinflamatória e analgésica contendo derivados n-acilidrazÈnicos do safrol, uso, e processo para sua preparação |
| ATE554759T1 (de) * | 2007-01-31 | 2012-05-15 | Guangzhou Zhongwei Biotechnology Ltd | Salzsaures gefriergetrocknetes piperphentonamin- pulver zur herstellung einer injektionslösung, herstellungsverfahren und verwendungen |
| CN103304561B (zh) * | 2013-06-21 | 2016-06-01 | 天津药物研究院 | 一类具有抗血栓作用的化合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4410540A (en) * | 1981-11-04 | 1983-10-18 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic 4-aroylimidazolidin-2-ones |
| CA1266268A (fr) * | 1985-10-15 | 1990-02-27 | J. Martin Grisar | Aroylthiazolones cardiotoniques |
-
2000
- 2000-06-21 CA CA002384525A patent/CA2384525C/fr not_active Expired - Fee Related
- 2000-06-21 AU AU56287/00A patent/AU5628700A/en not_active Abandoned
- 2000-06-21 WO PCT/US2000/017024 patent/WO2000078754A1/fr active Application Filing
- 2000-06-21 EP EP00941596A patent/EP1532140A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU5628700A (en) | 2001-01-09 |
| CA2384525C (fr) | 2007-03-06 |
| EP1532140A1 (fr) | 2005-05-25 |
| WO2000078754A1 (fr) | 2000-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1241528A3 (fr) | Composés polymérisables par radicaux pour l'enregistrement d'images | |
| WO2000012509B1 (fr) | Collecte de composes | |
| NZ512422A (en) | Novel thyroid receptor ligands and method II | |
| AU747521C (en) | Cycloalkene derivatives, process for producing the same, and use | |
| TWI256959B (en) | Aromatic liquid-crystalline polyester solution composition | |
| CA2328780A1 (fr) | Dihydropyrimidines | |
| CA2189603A1 (fr) | Derive de la propiophenone et methodes de preparation | |
| WO2003082798A8 (fr) | Composes naturels et leurs derives, destines a la prevention et au traitement de maladies cardiovasculaires, hepatiques, renales, et a des applications cosmetiques | |
| AU9107491A (en) | 1,4-benzothiazepine derivative | |
| EP1090922A3 (fr) | Composition organophosphorée, procédé de préparation d'un composé organophosphoré, composition de polyester et méthode pour la préparer | |
| KR910016915A (ko) | 과콜레스테롤혈증 치료제 | |
| CA2244139A1 (fr) | Derives de distamycine, procede de preparation de ces derives et leur utilisation en tant qu'agents antitumoraux et antiviraux | |
| PL378201A1 (pl) | Sposób farmaceutyczny oraz związki wytwarzane tym sposobem | |
| AU6729600A (en) | Novel isoindole derivatives | |
| CA2357038A1 (fr) | Compositions medicales contenant des derives de la 1,4-benzothiazepine pour le traitement de la fibrillation auriculaire | |
| CA2053820A1 (fr) | Methode d'inhibition du metabolisme du cholesterol | |
| EP0816415A3 (fr) | Composés polybenzimidazole en solution et procédé pour leur préparation | |
| EP1199072A3 (fr) | Méthodes de traitement des lésions du cartilage | |
| CA2384525A1 (fr) | Thienylhydrazone possedant des proprietes analogues a celles de la digitale (effets inotropes positifs) | |
| EP0781667A3 (fr) | Composition thermochromique réversible | |
| WO2004080408A3 (fr) | Methode de traitement du cancer a l'aide de compositions a base d'azaspirane | |
| WO1999035133A3 (fr) | Chelateurs constitues de derives d'acide 1,4,7,10-tetraazacyclododecane-1,4-diacetique | |
| AU7950100A (en) | 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof | |
| EP1122252A4 (fr) | Composes azotes hererocycliques condenses; procede de fabrication et agents les renfermant | |
| EP0982357A3 (fr) | Composition de polymère crystalline |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |